# Ye Ni as the joint first author 2 0 &Yan Qi-gui as the corresponding author 2 1 unqualified length were removed, and the remaining clean reads were aligned with the Capra 1 0 1 hircus genome in NCBI using Bowtie software to analyze the genomic distribution and 1 0 2 expression of small RNAs. The vast majority of clean reads (at least 84.75%) and unique 1 0 3 reads (at least 57.56%) mapped to the Capra hircus genome (Table 1) . 1 0 4
Unique reads were blasted against the Rfam, RepBase, EST and miRBase databases, in the 1 0 5 order of known miRNAs > rRNAs > tRNAs > snRNAs > snoRNAs > repeat sequences, 1 0 6 which enabled each small RNA obtain a unique annotation. To exclude other RNAs, such as 1 0 7 tRNAs, rRNAs, snRNAs and snoRNAs, the remaining sequences were mapped to Denovo 1 0 8
prediction data sets and the Capra hircus genome to identify novel miRNAs. Using miRDeep 1 0 9
prediction (Friedländer et al. 2008) and RNAfold (Hofacker et al. 1994 ) software to analyze 1 1 0 secondary structure. A total of 435 sequences (29 novel miRNAs) were included in the 1 1 1 miRNA library. Table S1 displays the sequencing generated codes and corresponding Capra 1 1 2 hircus miRNAs or novel miRNA_id. As research into miRNAs in human cancer is 1 1 3
widespread, we blasted all goat miRNAs against the human miRNAs in miRBase v21 to 1 1 4 further understand their function. A total of 615 of the goat miRNAs had analogues in the 1 1 5 human miRNA datasets (Table S2) . 1 1 6
Identification of differentially expressed miRNAs in ENA 1 1 7
A total of 435 miRNAs were identified in the ENA and para-carcinoma tissues. The table  1 1 8 S3 lists the expression of all miRNAs. The expression of 116 miRNAs was significantly 1 1 9 different in para-carcinoma tissues and ENA, of which 54 were downregulated and 60 were 1 2 0 upregulated in ENA. In addition, 2 miRNAs were only expressed in the para-carcinoma 1 2 1 tissues ( Table S4 ). The majority of the fold change-log 2 values ranged from 1 to 5.42; 1 2 2 chi-miR-133a-3p had the highest fold-change-log 2 of at least 5.4-fold, and 65 miRNAs had 1 2 3
fold-change-log 2 values of at least two-fold. Figure 8 indicates the differences in expression 1 2 4 of all 435 miRNAs between ENA and the para-carcinoma tissues. 1 2 5
Functional analysis of differentially expressed target genes regulated by differentially 1 2 6 expressed miRNAs 1 2 7 8
The Miranda algorithm indicated thousands of potential target genes for the 435 miRNAs. 1 2 8
According to the total scores and predicted energies, the 6176 non-redundancy target genes of 1 2 9
these 121 miRNA(116 significant expression miRNAs and 5 star miRNAs ) were selected, 1 3 0
reflecting 15222 corresponding relationships between the differentially expressed miRNAs 1 3 1
and their target genes. Table S5 shows the total stores, total energy, and protein-id and 1 3 2 genomic location of predicted target genes. 1 3 3
The expression of these candidate target genes was assessed in the high throughput 1
3 4 sequencing data obtained from the same ENA and para-cancerous tissue samples (data not 1 3 5
shown; this data will be described in another article). A total of 175 mRNAs that were 1 3 6 significantly differently expressed in ENA were selected for this analysis. Table S6 lists the  1  3  7 differentially expressed miRNAs and their corresponding differentially expressed target genes. 1 3 8 Table S7 summarizes the degree of regulation between the differentially expressed miRNAs 1 3 9
and their differentially expressed target mRNAs. 1 4 0
MiRNA-gene ontology network analysis of miRNA target genes 1 4 1
Functional analysis was conducted on the mRNAs predicted as targets of the 435 1 4 2 differentially expressed miRNAs. A total of 9777 GO enrichments were identified, of which 1 4 3 1792 GO categories were significant (P ≤ 0.05).The mRNA sequencing identified a total of 1 4 4 90 target genes corresponding to miRNAs with significantly decreased expression and 84 1 4 5
target genes corresponding to miRNA with significantly increased expression in tumor group. 1 4 6 472 significant GO enrichments exist in significant expression miRNA-mRNA network( Table  1 4 7 S8). The target genes of the differentially expressed miRNAs were mainly involved in cell 1 4 8 differentiation, MAP kinase activity, cell adhesion and angiogenesis; each of these pathways 1 4 9
MiRDeep (Friedländer et al. 2008) and RNAfold (Hofacker et al. 1994 )were used to predict 3 0 5 miRNA precursor sequences, star miRNAs and mature miRNAs, and then the energetic 3 0 6 stability, position and read frequencies for each potential miRNA precursor were computed 3 0 7
using miRDeep according to the compatibility of energetic stability, positions, frequencies of 3 0 8
reads. Ultimately, a Capra hircus nasal tissue miRNA library was created by combining the 3 0 9
sequencing data from all six samples. 3 1 0
Identification of differentially expressed miRNAs in ENA
The sequences in each sample were compared with the miRNA library established in this 3 1 2 study by assessing the numbers of transcripts per million (TPM). TPM was calculated as 3 1 3
(numbers of each miRNA matched to total reads)/(number total reads) x 10 6 . TPM is an 3 1 4
indicator of the quantity of miRNA expression per million match paired sequences. The total 3 1 5
numbers of matched pair reads were used in the normalized numerical expression algorithm 3 1 6
to calculate miRNA expression. DESeq (Anders and Huber 2010)software was used to 3 1 7 identify differentially expressed miRNAs between the para-carcinoma tissues (S2，S4, S6) 3 1 8
and ENA (S1, S3, S5) on the basis of a fold-change greater than or equal to two and P-value high-throughput sequencing allowed the mRNA expression of all of the potential target genes 3 2 8
to be analyzed in the same samples (data not shown); therefore, GO and KEGG analyses 3 2 9
could be conducted on the differentially expressed target genes of the differentially expressed 3 3 0 miRNAs. GO annotation and enrichment analysis was performed for three gene ontologies: 3 3 1 molecular function, cellular components and biological processes. The following formula was 3 3 2 used to calculate the P-values:
where N is the number of genes with GO/KEGG annotations; n is the number of target gene 3 3 6 candidates in N; M is the number of genes that annotated to a certain GO term/pathway, and m 3 3 7
is the number of target gene candidates in M. GO terms and KEGG pathways with a corrected 3 3 8 P-value ≤ 0.5 were regarded as significantly enriched. 3 3 9
Validation of the expression of key differentially expressed miRNAs 3 4 0
Key miRNAs that were identified in all of the analyses described above were quantified 3 4 1 in ENA and para-carcinoma tissue samples from five goats with ENA whose nasal passages 3 4 2 were unilaterally blocked by tumors. Total RNA was isolated and reverse transcribed as 3 4 3 described above, then the cDNA products were diluted 5-fold with sterile H 2 O and subjected 3 4 4
to quantitative real-time PCR (qPCR) using the All-In-One miRNA qRT-PCR Detection Kit 3 4 5
(GeneCopoela) with U6 snRNA and GAPDH as internal references. Each reaction contained 3 4 6 1 8
10 µL of 2x All-in-One qPCR Mix, 2 µL All-in-One miRNA qPCR Primer (2 µM; prepared 3 4 7
by Life Technologies, Shanghai, China), 2 µL Universal Adaptor qPCR Primer (2 µM), 2 µL 3 4 8
first-strand cDNA and 4 µL double distilled water. The cycling conditions were 95°C for 10 3 4 9
min, 40 cycles of 95°C for 10 s, 60°C for 20 s and 72°C for 20 s, followed by melting curve 3 5 0 analysis. Relative quantification was performed using the 2 -△ △ Ct method (Livak and 3 5 1
Schmittgen 2001), and t-tests were used to examine the significance of the differences in 3 5 2 expression between the para-carcinoma tissues and ENA. 3 5 3
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